Rescheduled - Dr. Jason Sicklick of Moores Cancer Center at UCSD will present a webcast detailing the Phase II study of Temozolomide in advanced SDH-mutant/deficient GIST, a new study available to patients with SDH-deficient GIST.
This webcast was originally recorded May 21, 2019. Follow this link for webcast with Hebrew Subtitles. Listen to the webcast - Hebrew subtitles Are you interested in optimizing your treatment? In [...]
Genetic Testing and SDHx Mutations: What do they have to do with PGL/GIST/Pheos? LISTEN TO WEBCAST This webcast will highlight how SDHx mutations impact risks for paraganglioma, pheochromocytomas, and GIST. We’ll discuss [...]
GI Stromal Tumors: A PatholoGIST's Point of View Mutational Testing in GIST Mutational Testing in GIST is a vital component for survival, especially as cancer treatment becomes more individualized. In this webcast, Dr. Chris [...]